SecBot SecBot
PRESS-RELEASE ·Filed Apr 17, 2026

VXRT

Vaxart, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed7mo ago WireGlobeNewswire
Press release · Regulatory
Actionable Insight • Neutral

Traders should monitor for future 8-Ks indicating actual drawdowns under this facility, which would signal immediate dilution. Absent such filings, this is a standby financing tool with minimal near-term impact. Watch for downward pressure on share price if draws occur during weak market conditions.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.7500
T+0 close · Apr 17, 2026 · via day close
Latest settled
−26.67%
T+60 · $0.5500
Vs SPY
−32.81%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 17 $0.7500entry
  2. T+1 · 7mo ago +1.33%α +1.52% · $0.7600
  3. T+5 · 7mo ago −4.00%α −4.55% · $0.7200
  4. T+20 · 6mo ago −13.33%α −18.70% · $0.6500
  5. T+60 · 4mo ago −26.67%α −32.81% · $0.5500

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vaxart announced a $25 million at-the-market equity financing facility with Lincoln Park Capital, allowing the company to sell shares at its discretion over 24 months. The agreement provides non-dilutive flexibility but does not guarantee any funding, as Vaxart controls the timing and amount of sales.

Key Financial Metrics

Deal Value
$25.0M

Key Facts

  • Vaxart entered into a share purchase agreement (SPA) with Lincoln Park Capital Fund for up to $25 million in common stock sales over 24 months.
  • Vaxart has sole discretion over the timing and amount of sales; Lincoln Park is obligated to buy at prevailing market prices with no price cap.
  • No warrants, rights, or short-selling by Lincoln Park are permitted.
  • A registration statement must be declared effective by the SEC before any sales can occur.
  • The company issued shares to Lincoln Park as commitment consideration, though the amount is not disclosed.

Financial Impact

Up to $25 million in potential gross proceeds, subject to market conditions and Vaxart's discretion.

dilutioncashequity

Risk Factors

  • Potential share dilution if Vaxart draws significantly on the facility, especially in a declining stock price environment.
  • Market perception of equity lines as a 'last resort' financing could negatively impact sentiment despite no immediate dilution.

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3276132

Track record

23 reports on VXRT

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +37.66% at T+60 after the May 1, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $0.3700 Now $0.3600 +2.70% settles Feb 4
  2. Oct 19, 202628d ago 8-K Neutral 3/10 Entry $0.4900 Now $0.3600 −26.53% settles Jan 15
  3. Jul 28, 202615w ago 8-K Neutral 2/10 Entry $0.4800 to $0.4900 Now $0.3600 −25.00% ▲ +2.08% −2.53% vs SPY
  4. Jul 7, 202618w ago 8-K Neutral 4/10 Entry $0.5500 to $0.4500 Now $0.3600 −34.55% ▼ −18.18% −21.27% vs SPY
  5. Jul 6, 202619w ago DEFA14A Neutral 5/10 Entry $0.6200 to $0.4540 Now $0.3600 −41.94% ▼ −26.77% −28.93% vs SPY
  6. Jul 2, 202619w ago DEFA14A Bullish 5/10 Entry $0.6400 to $0.4500 Now $0.3600 −43.75% ▼ −29.69% −33.51% vs SPY
  7. Jul 2, 202619w ago 8-K Neutral 4/10 Entry $0.6400 to $0.4520 Now $0.3600 −43.75% ▼ −29.38% −32.80% vs SPY
  8. Jun 26, 202620w ago DEFA14A Neutral 4/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  9. Jun 26, 202620w ago DEFA14A Neutral 3/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  10. Jun 26, 202620w ago 8-K Mixed 5/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026